Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01679496Not ApplicableCompleted

Fat Quality on Blood Lipids and Immune Response

Role: collaborator

NCT03658681Not ApplicableCompleted

Effect of Fat Quality on Glycemic Regulation and Gut Microbiota After a Short-time Intervention in Healthy Individuals

Role: collaborator

NCT02223793Not ApplicableUnknown

Vascular Lifestyle-Intervention and Screening in Pharmacy

Role: collaborator

NCT03293693Not ApplicableCompleted

Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects

Role: collaborator

NCT02729857Not ApplicableCompleted

Postprandial Response After Intake of Meals With Different Fatty Acid Composition

Role: collaborator

NCT00485095Phase 4Completed

The Effect of Plant Sterol Supplement on Blood Cholesterol

Role: collaborator

All 6 trials loaded